Counterfeit medicines have become an enormous problem in many parts of the world. EU has introduced the Falsified Medicines Directive, which is here to help prevent prescription drugs from being misbranded, sold after expiry, counterfeited, diverted, stolen and contaminated. All manufacturers, wholesalers, re-packagers, OEMs and pharmacies must adapt to the new regulatory landscape. There is no doubt that serialisation will change the way companies are distributing their products. Packaging, commercial relationships with customers, regulatory...

Counterfeit medicines have become an enormous problem in many parts of the world. EU has introduced the Falsified Medicines Directive, which is here to help prevent prescription drugs from being misbranded, sold after expiry, counterfeited, diverted, stolen and contaminated. All manufacturers, wholesalers, re-packagers, OEMs and pharmacies must adapt to the new regulatory landscape. There is no doubt that serialisation will change the way companies are distributing their products. Packaging, commercial relationships with customers, regulatory activities, and the way they are managing their data will be heavily impacted as well. It will also trigger the wave of challenges companies will be facing: in their manufacturing, operations and supply chain management processes. This is the exact reason we decided to run this event and provide a platform for an essential dialog between pharma companies and CMOs, CPOs, CDMOs. Global pharma companies will learn how to build enterprise-wide strategies and technology infrastructures to handle the markets on a consistent way. And contractors will have an opportunity to discuss how to handle different requirements from different customers. The event will be covering a range of real life case studies: starting from the impact serialisation has on company’s management processes, how to find a qualified supplier, how to fund the changes in packaging lines, all the way to IT matters. Knowledge sharing provided at this event will ensure that all industry players are ready to successfully face regulatory deadline.